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CASE PRESENTATION
A 42-year-old Caucasian woman with AIDS presented
with new onset severe lower extremity edema and
progressive renal failure. She had a 14-year history of HIV
infection acquired from intravenous drug use. At the time
of admission, she was being treated with highly active
antiretroviral therapy. Her AIDS-defining illness was an
episode of pneumocystis pneumonia several years before
admission.
One month before admission, she presented with fever
and mental status changes associated with cryptococcal
fungemia. Blood cultures were positive for Cryptococcus
neoformans sensitive to amphotericin B and fluconazole. She
underwent 2 weeks of therapy with intravenous amphoter-
icin B and 5-fluocytosine, after which she improved clinically
and was switched to oral fluconazole. Repeat blood cultures
were negative for growth; however, there was persistence of
cryptococcal antigenemia. Her serum creatinine at the time
of discharge was 2.2 mg/dl (194mmol/l), increased from
baseline creatinine of 0.9 mg/dl (80mmol/l) 3 months before
admission. Review of urinalyses available before admission
showed intermittent trace proteinuria without evidence of
casts, crystalluria, pyuria, or hematuria. She denied recent
travel or exposure to birds and did not have any pets.
Medical therapy consisted of lamivudine/ziduvidine
(Combivirs), efavirenz (Sustivas) and fluconazole.
On physical examination, the patient appeared chroni-
cally ill and weighed 111 kg. She was afebrile with a blood
pressure of 151/80 mm Hg. There was no jugular venous
distension, thyromegaly, or lymphadenopathy. Cardiac
examination was remarkable for a grade 2/6 holosystolic
murmur at the left apex radiating to the axilla. The lungs
were clear to auscultation and percussion. There was
hepatosplenomegaly. The extremities revealed 2/4 pitting
edema and erythema, with no clubbing or splinter hemo-
rrhages. Neurologic examination revealed no meningismus,
and normal sensory, motor, and cranial nerve examinations.
Laboratory values on admission were as follows: blood
urea nitrogen, 66 mg/dl (24 mmol/l) (normal range
8–18 mg/dl (3–6.5 mmol/l)); serum creatinine, 2.7 mg/dl
(239mmol/l); serum albumin, 2.9 g/dl (29 g/l) (normal
range 3–5 g/dl (30–50 g/l)); and 24 h urine protein
5 g. Serum sodium, potassium, bicarbonate, chloride,
transaminases, and bilirubin were within normal limits.
Urinary indices: random urine sodium 109 mmol/l, random
urine creatinine 19 mg/dl, urine osmolality 254 mOsm/kg
(254 mmol/kg), and fractional excretion of sodium 11.4%.
White blood cell count was 4.5 106/l (normal range
4.5–11 106/l), white blood cell count differential:
segmented neutrophils 80% (normal range 54–62%), band
forms 1% (normal range 3–5%), lymphocytes 9% (normal
range 25–33%), and monocytes 10% (normal range 3–7%).
Other laboratory values on admission included hemo-
globin, 8.6 g/dl (86 g/l) (normal range 13–16 g/dl (130–160 g/l);
platelet count, 58 109/l (normal range 150–500 109/l);
and helper T-lymphocytes (CD4) cell count, 137/mm3
(normal range 500–1500/mm3). Peripheral blood smear
revealed 2þ red blood cell polychromasia and 2þ
schisocytosis. Urinalysis showed specific gravity 1.010,
300 mg/dl of protein, and negative nitrite. Microscopic
examination of the urine revealed 50 white blood cells per
high-power field, 20 red blood cells per high-power field,
negative yeast, no crystalluria, no casts, and negative
bacteria. Wright’s stain revealed no urinary eosinophils.
Urine culture, urine India ink, and urine mucicarmine
stains were not performed. Serum complement levels
were normal. Hepatitis C antibody was positive. Hepatitis
B antibody and surface antigen were negative. Chest
radiograph was unremarkable. Echocardiogram showed
normal valvular structures without any evidence of
vegetations. Magnetic resonance imaging of the brain
revealed no mass lesions. Computed tomographic scan
of the abdomen revealed no renal masses, perinephric
stranding, or fluid collections. Renal ultrasound showed
normal-sized kidneys (right kidney 11.5 cm and left kidney
11.8 cm) with preserved cortico-medullary differentiation.
There was no evidence of calyectasis or hydronephrosis.
Owing to acute renal failure (ARF) and nephrotic-range
proteinuria, a renal biopsy was performed.
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KIDNEY BIOPSY FINDINGS
Light microscopic examination disclosed one core of
renal cortex containing 14 glomeruli, none of which were
sclerotic. The glomerular capillary lumina were massively
dilated and occluded by abundant fungal organisms (some-
times numbering over 20 per glomerulus) surrounded
by macrophage reaction (Figure 1a). The fungi consisted
of rounded yeast forms ranging from 5 to 10 mm in thick-
ness, with a thick capsule and rare budding forms. The
yeast stained periodic acid Schiff-positive, silver-positive,
and mucicarmine-positive (Figure 1b), consistent with
Cryptococcus neoformans. The macrophage reaction included
foamy histiocytes and scattered giant cells. In some
glomeruli, cryptococcal organisms were also seen free within
the urinary space associated with extracapillary macro-
phage reaction. No glomeruli with collapsing sclerosis, seg-
mental sclerosis, or intravascular fibrin thrombi were seen.
Cryptococcal organisms were also identified focally within
tubular lumina, tubular epithelial cells, and the interstitium,
producing ‘bubbly’ zones of interstitial clearing with granulo-
matous reaction (Figure 1c). Proximal tubular cells con-
tained focal intracytoplasmic protein and lipid resorption
droplets. There were scattered proteinaceous casts and red
blood cell casts. Tubular atrophy and interstitial fibrosis
involved approximately 15% of the cortex. Approximately
30% of the cortex displayed interstitial expansion by
edema and mild to moderate inflammatory infiltrates of
mononuclear leukocytes. Arteries and arterioles were un-
remarkable.
Ten glomeruli were studied by immunofluorescence
and showed 2þ luminal positivity for C3 in the distribu-
tion of the yeast capsules (Figure 1d) and 3þ positivity
for fibrinogen. There was also weak segmental granular
capillary wall positivity for C3 and granular mesangial
positivity for immunoglobulin IgM (1–2þ ), k (1þ ), and
l (1þ ). Staining for IgG, IgA, C1q, and albumin was
negative.
By electron microscopy, many glomerular capillary
lumina were occluded by fungal organisms surrounded by
macrophages. Fungi were also identified in the tubular
lumina and interstitium (Figure 1e). The fungi exhibited a
thick spherical capsule with radially oriented fibrillar
substructure typical of Cryptococcus neoformans (Figure 1f).
Some of the intracapillary macrophages formed foam
cells. The glomerular endothelium appeared swollen with
obliteration of fenestrations. Scattered endothelial tubulo-
reticular inclusions were identified. There was focal
subendothelial accumulation of fibrin tactoids involving
several capillaries with organisms. Approximately 5% of
capillaries sampled also had sparse small subepithelial
or intramembranous electron-dense deposits, some of
which were separated by short basement membrane spikes.
Foot process effacement involved approximately 60% of
the glomerular capillary surface area, predominantly over-
lying capillaries distended by intraluminal fungi and macro-
phages.
FINAL DIAGNOSIS
Cryptococcal pyelonephritis, severe, involving glomerular
and tubulointerstitial compartments.
CLINICAL FOLLOW-UP
The patient was maintained on highly active antiretroviral
therapy therapy. After having received 2 weeks of liposomal
amphotericin B and 5-fluocytosine, she was continued on
400 mg of fluconazole daily. Her serum creatinine declined
and then stabilized at 2.3 mg/dl (203 mmol/l). She continued
to have proteinuria in the range of 2.0–2.5 g/24 h. Repeat
urinalysis revealed specific gravity of 1.010, 300 mg/dl
proteinuria, negative leukocytes, positive blood, and negative
nitrite. Microscopic examination of the urine showed three to
five red blood cells per high-power field. Repeat blood
cultures were negative. Five months post-discharge, she died
at home of a cardiopulmonary arrest.
DISCUSSION
ARF is a common complication of HIV infection. Patients
may present with a variety of patterns of renal involvement.
ARF is usually secondary to pre-renal causes or acute tubular
necrosis related to sepsis, hypotension, or nephrotoxic
agents.1,2 Differential diagnosis of ARF owing to nephrotoxic
agents includes drug toxicity from antifungal agents such as
amphotericin B, acute tubular necrosis due to aminoglyco-
sides, acute interstitial nephritis owing to sulfonamides,
nephrotoxicity related to antiretroviral agents employed
in highly active antiretroviral therapy therapy, and nephro-
lithiasis secondary to indinavir. Thrombotic microangio-
pathy and direct renal parenchymal infections by to
opportunistic organisms are other potential causes of ARF
in the HIV-infected patient.2 Renal parenchymal infection
by a variety of pathogens has been reported, including fungi
(Candida, Cryptococcus, Histoplasma, Aspergillus, Pneumo-
cystis), protozoa (Toxoplasma), viruses (cytomegalovirus,
adenovirus, polyomavirus), and bacteria (Mycobacteria,
Pseudomonas). When renal failure occurs in association with
nephrotic-range proteinuria, differential diagnosis includes
HIV-associated nephropathy (focal segmental glomerulo-
sclerosis) and a variety of forms of glomerulonephritis,
including acute post-infectious glomerulonephritis, IgA nephro-
pathy, ‘lupus-like’ immune complex glomerulonephritis,
and membranoproliferative or membranous glomerulonephritis
related to hepatitis C or hepatitis B infection.1,3,4
Cryptococcus neoformans is a ubiquitous yeast with
worldwide distribution. The fungus is present in the soil
and in pigeon droppings. The respiratory tract is the usual
portal of entry. The pulmonary infection is usually
asymptomatic, but may cause pneumonia or pulmonary
nodules. From the lungs, the fungus may disseminate to
other organs, especially the central nervous system, causing
meningoencephalitis. Cryptococcal disease mainly affects
immunosuppressed individuals (especially patients with
AIDS or malignancies and transplant recipients), although
it may infect immunocompetent patients as well. The
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cryptococcal yeast measures 4–6 mm in diameter and stains
eosinophilic in tissue sections. It is surrounded by a halo
corresponding to its mucinous capsule, which can be revealed
with the mucicarmine stain. Human infection with capsule-
deficient Cryptococcus has been described. The capsule-
deficient Cryptococcus is mucicarmine-negative, but can be
identified with the Fontana–Masson silver stain. The nature
of the tissue response to cryptococcal infection depends on
the immune status of the patient. Immunocompetent
patients develop a chronic granulomatous reaction composed
of lymphocytes, macrophages, and foreign-body giant cells,
whereas immunocompromised patients may have extensive
fungal tissue invasion with minimal inflammatory reaction.
Autopsy rates of renal involvement in disseminated
cryptococcosis are high, ranging from 26 to 45%.5,6 In a
post-mortem study of patients with AIDS, cryptococcal
infection with multi-organ involvement was noted in 23 of
252 (9.1%) patients, of which 26% had renal involvement.7
The renal infection is often clinically silent. Renal dysfunction
occurring during disseminated fungal infection is more
frequently due to nephrotoxicity of amphotericin B or sepsis
than direct renal parenchymal infection. Very rarely,
cryptococcal pyelonephritis can be the first manifestation of
the systemic disease.8
The major histologic manifestations of renal cryptococ-
cosis include histologically identifiable renal infiltration by
fungal organisms, severe interstitial inflammation, granulo-
ma formation, and tubulitis.9,10 Cryptococcal localization in
glomeruli has occasionally been described.5,10 Cryptococcal
pyelonephritis may lead to papillary necrosis.8 Urine cultures
and staining of the spun urine with mucicarmine or India ink
stains are helpful diagnostic tests.
In the HIV population, there are only rare reports of
cryptococcal renal infection causing proteinuria or ARF.
Praditpornsilpa et al. studied the renal pathology of 26 HIV-






Figure 1 | Renal biopsy findings. (a) Glomerular capillaries are massively distended by abundant intracapillary yeast forms surrounded by
numerous histiocytes. The yeast forms have a thick periodic acid Schiff-positive cell wall. A rare budding form is present (arrow) (original
magnification,  400). (b) Mucicarmine stain highlights the characteristic mucinous capsule of the Cryptococcus (original magnification,  400).
(c) Tubules are splayed apart by an interstitial granuloma containing swollen histiocytes and abundant yeast forms. The interstitium has focal
clearing, imparting a ‘bubbly’ appearance. A portion of a glomerular tuft is seen at the top of the field (periodic acid Schiff, original
magnification,  200). (d) There is high-intensity immunofluorescence positivity for C3 outlining yeast capsules within glomerular
capillary lumina. Focal granular capillary wall positivity is also seen in the glomerular basement membrane (original magnification,  600).
(e) A low-power electron micrograph shows an intra-tubular ‘cast’ of aggregated cryptococcal organisms in a granular matrix (original
magnification,  2000) (f). A high-power electron micrograph of a single, intra-tubular cryptococcal organism shows a thick, clear capsule
surrounding the electron-dense cell wall (original magnification,  10 000).
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On renal biopsy, 17 patients had mesangioproliferative
glomerulonephritis, two IgA nephropathy, two membranous
glomerulopathy, two diffuse proliferative glomerulonephritis,
one tuberculous granulomatous interstitial nephritis, and
two cryptococcal interstitial nephritis accompanied by mild
mesangial proliferation; none developed HIV-associated
nephropathy. The two patients with renal cryptococcosis
had serum creatinine values of 1.6 mg/dl (141 mmol/l) and
1.0 mg/dl (88 mmol/l), and 24-h urine protein values of 1.6
and 3.0 g/day, respectively.11 Treatment protocols for crypto-
coccal pyelonephritis in AIDS patients are not well defined.
Our patient was treated with the same regimen generally
recommended for AIDS patients with central nervous system
or disseminated cryptococcosis, namely IV amphotericin B
(0.7–1.0 mg/kg/day) plus oral flucytosine (100 mg/kg/day) for
2 weeks, followed by oral fluconazole (200–400 mg/day) for
life.12
The pathogenesis of ARF owing to extensive fungal
infections has not been fully elucidated. In an experimental
model of renal candidiasis, localization of organisms in
glomeruli and peritubular capillaries through adhesion to
endothelium occurred within 5 min of injection of viable
Candida albicans directly into the renal artery, followed
within hours by the formation of intracapillary neutrophilic
nodules containing yeasts, and within days by fungal invasion
into the tubulointerstitial compartment associated with
inflammation and abscess formation.13 In an experimental
study of pyelonephritis in rats, interstitial nephritis occurred
3 days after intrarenal injection of Cryptococcus neoformans
and the fungi persisted for 6–8 weeks. Over subsequent
weeks, the interstitial inflammation continued in the absence
of identifiable fungal antigens, accompanied by progressive
renal scarring.14 Cryptococcal production of a serine
proteinase that cleaves type IV collagen, fibronectin, and
laminin likely facilitates tissue invasion.15 The subsequent
interstitial inflammation is probably enhanced by crypto-
coccal-stimulated release of chemoattractant cytokines such
as macrophage inflammatory peptide-1a (MIP-1a), MIP-1b
and RANTES by monocytes and T cells.16
In the case reported herein, the pathological finding of
foot process effacement overlying capillaries containing
fungal organisms with surrounding mononuclear cell reac-
tion suggests that proteinuria may develop as a consequence
of intraglomerular cryptococcal infection and the intracapil-
lary release of inflammatory mediators. In patients with
sepsis, recognition of pathogenic motifs by toll-like receptors
on podocytes with upregulation of B7-1 may play a role in
the mediation of foot process effacement and the develop-
ment of proteinuria.17 The immunofluorescence finding of
staining for C3, without co-deposits of immunoglobulin or
C1q, in the distribution of the yeast capsules supports
complement activation by the alternative pathway. The few
subepithelial and intramembranous electron densities in
capillaries containing organisms may represent in situ
immune complex formation following planting of locally
released cryptococcal antigen in the course of glomerular
capillary infection. The absence of well-developed, regular
membranous features argues against hepatitis C-associated
membranous glomerulopathy. The glomerular staining for
fibrinogen and the ultrastructural demonstration of sub-
endothelial fibrin tactoid formation, indicating cross-linked
fibrin, support a concurrent local activation of the coagula-
tion cascade following endothelial injury.
In summary, the diffuse glomerular involvement by
cryptococcal infection in this HIV-infected patient is extre-
mely unusual and accounts for the dual presentation with
heavy proteinuria and ARF. The possibility of glome-
rular cryptococcosis should be entertained in HIV-infected
patients or other immunocompromised patients who present
with proteinuria and renal dysfunction in the clinical setting
of disseminated cryptococcal infection.
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